The Cost-effectiveness Analysis of Continuous Intrathecal Morphine Infusion in Cancer Pain Management
- Conditions
- Cost-effectiveness of continuous intrathecal morphine infusion in cancer pain management.cost, effectiveness, continuous intrathecal morphine infusion, cancer pain
- Registration Number
- TCTR20210607005
- Lead Sponsor
- /A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
1.Age over 18 years old
2.Duration of cancer pain more than 3 months
3.Control pain with continuous intrathecal morphine infusion
Exclusion Criteria
1.Patient die within 1 month after receive continuous intrathecal morphine infusion.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hospital and patient direct cost before and after having ITT price (baht)
- Secondary Outcome Measures
Name Time Method analgesic requirement before and after having ITT milligrams morphine equivalent,pain intensity before and after having ITT numeric rating scale (NRS),functional and performance status before and after having ITT palliative performance scale (PPS)